Navigation Links
French Government Agrees to Fund Study of the PneumRx RePneu Lung Volume Reduction Coil
Date:7/30/2012

MOUNTAIN VIEW, Calif., July 30, 2012 /PRNewswire/ -- PneumRx, Inc. (www.pneumrx.com), a leader in the field of interventional pulmonology, today announced that the French Ministry of Health has approved a cost-effectiveness study of the RePneu Lung Volume Reduction Coil (RePneu LVRC) in France. The Ministry of Health agreed to fund the study under the soutien aux techniques innovantes couteuses (STIC) program, which provides government funding for innovative medical technologies that have been validated by prior clinical studies, with a view toward establishing reimbursement for new devices.

(Logo: http://photos.prnewswire.com/prnh/20120514/SF06703LOGO)

The PneumRx study is one of only two STIC projects selected by the Ministry of Health for funding in 2012, and the first in the field of emphysema treatment since 2006. The French Government has committed to paying 1.3 Million Euros ($1.6 Million) to support this PneumRx study. The protocol, entitled "Evaluation Medico-Economique de la Reduction Volumique par Voie Endobronchique au Moyen de Spirales (REVOLENS)" (Medico-Economic Evaluation of Endobronchial Volume Reduction Using Coils), was submitted by Professors Gaetan Deslee of the University Hospital of Reims and Charles-Hugo Marquette of the University Hospital of Nice and is scheduled to begin enrolling patients in France in January, 2013.

The RePneu LVRC System is a minimally invasive device intended to improve lung function in emphysema patients by bronchoscopically implanting Nitinol coils into the lungs to compress diseased tissue (lung volume reduction), restore elastic recoil, and adjust lung compliance. This treatment offers a minimally invasive alternative to lung volume reduction surgery to a broad range of emphysema patients. 

The RePneu LVRC has already undergone extensive clinical studies in
'/>"/>

SOURCE PneumRx, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pycnogenol® (French Maritime Pine Bark Extract) Shown To Improve Endothelial Function And Reduce Oxidative Stress In New Clinical Trial
2. Northwest Bio Awarded $5.5 Million German Government Grant
3. U.S. Government Supports Phase 3 Study of Bavarian Nordics Smallpox Vaccine
4. Remote Patient Monitoring Devices Market to 2017 - Chronic Disease Prevalence and Government Curbs on Hospital Spending to Drive the Market
5. Government Affairs Groups Play Critical Role in Protecting Organizations in Turbulent Times
6. Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash
7. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
8. Sonendo Agrees To Terms For Up To $20 Million In Financing
9. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
10. Study Showed Patients Treated With The miraDry┬ę System Experienced 82 Percent Sweat Reduction On Average
11. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... -- Berger & Montague, P.C., a full-spectrum class ... one of the largest and most successful whistleblower ... Faruqi, LLP in settling three separate but related ... Cephalon, Inc., and Biogen, Inc., for a total ... agreements, AstraZeneca will pay the largest sum, $46.5 ...
(Date:7/7/2015)... July 7, 2015 A power morcellator lawsuit ... been settled for an undisclosed amount, Bernstein Liebhard LLP ... in March 2014 in the U.S. District Court, Eastern ... of a widower whose wife had died in February ... hysterectomy that involved the use of a power morcellator. ...
(Date:7/7/2015)... Juli 2015 Sequent Medical, ein ... Entwicklung innovativer Geräte für die Behandlung neurovaskulärer ... von R. Michael Kleine in den ... verfügt über eine mehr als 25-jährige Erfahrung ... hat verschiedene globale biomedizinische Unternehmen erfolgreich geleitet ...
Breaking Medicine Technology:AstraZeneca, Cephalon, and Biogen Idec to Pay $55.5 Million to Resolve False Claims Act Allegations Made By Whistleblower Ronald Streck 2AstraZeneca, Cephalon, and Biogen Idec to Pay $55.5 Million to Resolve False Claims Act Allegations Made By Whistleblower Ronald Streck 3Lina Medical, Power Morcellator Lawsuit Plaintiff Reach Settlement in Case Scheduled for November Trial, Bernstein Liebhard LLP Reports 2Lina Medical, Power Morcellator Lawsuit Plaintiff Reach Settlement in Case Scheduled for November Trial, Bernstein Liebhard LLP Reports 3Sequent Medical beruft Mike Kleine in den Aufsichtsrat 2Sequent Medical beruft Mike Kleine in den Aufsichtsrat 3
... a wholly-owned subsidiary of Integrated BioPharma,Inc. (NASDAQ: ... of vaccines against HPV, anthrax and plague ... The,studies were conducted by the Fraunhofer USA ... Organization led by Dr.,Vidadi Yusibov, through which ...
... Profile and Excellent,Pharmacokinetic Properties -, RESEARCH TRIANGLE PARK, ... a clinical stage company developing and,commercializing innovative treatments ... top-line results from a Phase I,clinical trial of ... and anxiety. In this study, Tyrima was safe ...
Cached Medicine Technology:Integrated BioPharma's Proprietary Vaccine Technology Achieves,Strong Positive Results 2CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 2CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 3
(Date:7/7/2015)... Aspen, CO (PRWEB) , ... July 07, 2015 ... ... 726 skin cancer screenings at the Aspen Ideas Festival (AIF), identifying 18 possible ... These potential diagnoses must be confirmed with additional testing. , The Aspen Ideas ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... Times highlights rumors about possible facial rejuvenation that have emerged about Hillary Clinton. ... U.S. Secretary of State looks more youthful than she has in some time ...
(Date:7/7/2015)... ... July 07, 2015 , ... Celestix Networks, the ... and CelestixFederated VA Series virtual appliances. These virtual platforms expand the existing ... which have proven to simplify the on-premises deployment of unified remote access and ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... advanced delivery technologies and development solutions for drugs, biologics and consumer health ... Excelimmune, Inc. to access its antibody combination therapy (ACT) technology platform. The ...
(Date:7/7/2015)... ... July 07, 2015 , ... The ... experience for its patient community using its IDF ePHR, an electronic personal health ... immunodeficiency diseases (PI) to easily track their health information, including symptoms, diagnoses, medications, ...
Breaking Medicine News(10 mins):Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 4Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 4Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3
... , FRIDAY, Nov. 5 (HealthDay News) -- People undergoing cancer ... possible and avoid exertion, to save all their strength to ... physicians and researchers now say that people who remain physically ... to beat cancer. The positive evidence for exercise during ...
... , FRIDAY, Nov. 5 (HealthDay News) -- Falls from tree ... an Ohio State University study. Researchers analyzed 130 hunting-related ... found that 50 percent of injuries were caused by falls, ... Among the other findings: , Gunshot wounds accounted ...
... , FRIDAY, Nov. 5 (HealthDay News) -- Over ... inflammatory kidney disorder known as lupus nephritis have vastly improved, ... with lupus nephritis, which is a complication that can occur ... can now expect a better quality of life, without many ...
... sent to physicians the moment they ordered a blood ... that is often false-positive for the elderly, according to a ... of Managed Care . The D-dimer test, combined ... of deep vein thrombosis (blood clots in veins, otherwise known ...
... Nov. 5 (HealthDay News) -- New genetic mapping of ... a particular gene mutation are particularly well-skilled in the ... between a specific variation of the so-called "PCSK6 gene" ... hard evidence to suggest that there could be an ...
... DC A large national study finds that screening current ... deaths from lung cancers by 20 percent. One potential ... up tumors at an early stage. The study was ... the country including Georgetown Lombardi Comprehensive Cancer Center, a part ...
Cached Medicine News:Health News:To Best Fight Cancer, New Guidelines Urge Exercise 2Health News:To Best Fight Cancer, New Guidelines Urge Exercise 3Health News:To Best Fight Cancer, New Guidelines Urge Exercise 4Health News:Lupus Kidney Disorder Treatment Improved Over Decade: Review 2Health News:Real-time physician electronic alerts reduce unnecessary blood testing in elderly patients 2Health News:Real-time physician electronic alerts reduce unnecessary blood testing in elderly patients 3Health News:Research Suggests Link Between 'Handedness' and Dyslexia 2Health News:National study shows CT screening of former, current smokers reduces lung cancer deaths 2Health News:National study shows CT screening of former, current smokers reduces lung cancer deaths 3
... pipette is ideal for repeated ... Fixed volume FInnpipettes offer the ... other Finnpipette Digital pipettes: ... (1-40ul), Soft-touch tip ejection, Safety ...
... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features:Eppendorf "pipette/tip" system ensures ...
250L...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
Medicine Products: